Platform

Growth equity is one of the fastest growing private equity strategies in the market today. TPG was early to recognize this opportunity, launching TPG Growth in 2007 to meet the unique needs of earlier-stage companies, from traditional minority growth investing to growth buyouts and specialty capital. TPG’s West Coast roots, value-added operating approach, global reach, and sector depth give us a distinct advantage in growth investing and position us as a valued partner for entrepreneurs.

$18.1B

AUM

Established in 2017, TPG Digital Media (TDM) is a flexible source of capital created specifically to pursue investment opportunities in digital media. TDM leverages TPG’s long history of studying and pursuing themes around the creation and distribution of content to build market-leading businesses in attractive verticals within the digital media landscape.

$1.8B

AUM

TPG Technology Adjacencies (TTAD) developed organically out of our technology investing practice in 2018. We saw significant value being created in the private markets as tech companies increasingly opted to stay private through more advanced stages of growth. This is a new era in the technology market that requires flexible capital with a full-suite, full-cycle approach to investing, and we created TTAD specifically for this opportunity.

$6.7B

AUM

As the pace of research, development, and innovation in the life sciences sector accelerates, TPG is uniquely positioned to be a capital provider of choice to emerging leaders. TPG Life Sciences Innovations (LSI) is a new strategy that will invest in companies that are developing new therapeutic modalities, biologics, and small molecules, as well as later-stage opportunities in digital health, medical devices, diagnostics, and innovation services.

$2.5B

in historical TPG life sciences investments